investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Targeting Chromatin Modifications in Leukemia with Trisomy 21

Andrew A Lane

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Craig B Thompson

Role of IDH Mutations in Acute Myeloid Malignancies

Leukaemia

Thomas Waldmann

IL-2/IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design

Leukaemia

Pathology Hematology and hematologic malignancies

Margaret A Goodell

Regulation of Hematopoietic Progenitors by de novo DNA Methylation

Leukaemia

David Marc Weinstock

Polysomy 21 in Acute Lymphoblastic Leukemia

Leukaemia

Scott Moore Carlson

The role of PRDM1 in epigenetic regulation and tumor suppression

Leukaemia

Scott W Lowe

The impact of chromosome 17p lesions on leukemogeneis and therapy response

Leukaemia

Pathology Hematology and hematologic malignancies

Alan Rein

Retrovirus Assembly and Maturation – Rockville

Leukaemia

Pathology Hematology and hematologic malignancies

Effie W Petersdorf

Clinical Significance of MHC Haplotypes in HCT

Leukaemia

Kim O'Neill

Cancer Immunology Research at Brigham Young University

Leukaemia